102 related articles for article (PubMed ID: 26866952)
1. In Reply: De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain.
Nakamura M; Krauss JK
Neurosurgery; 2016 Apr; 78(4):E602-3. PubMed ID: 26866952
[No Abstract] [Full Text] [Related]
2. Letter: De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain.
Scott RM
Neurosurgery; 2016 Apr; 78(4):E602. PubMed ID: 26866951
[No Abstract] [Full Text] [Related]
3. De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain.
Nakamura M; Samii A; Lang JM; Götz F; Samii M; Krauss JK
Neurosurgery; 2016 Apr; 78(4):E596-600. PubMed ID: 26382859
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
[TBL] [Abstract][Full Text] [Related]
5. [Research on chondrogenic differentiation and immunologic response of allogeneic mesenchymal stem cells implanted into joint cavity].
Zhao ZY; Yang L; Xu P; Yang C; Xu XX
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(20):1340-3. PubMed ID: 16271250
[TBL] [Abstract][Full Text] [Related]
6. Development of a de novo arteriovenous malformation after severe traumatic brain injury.
Miller BA; Bass DI; Chern JJ
J Neurosurg Pediatr; 2014 Oct; 14(4):418-20. PubMed ID: 25084086
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Conditioned Bone Marrow-Derived Mesenchymal Stem Cells Promote De Novo Functional Enteric Nerve Regeneration, but Not Through Direct-Transdifferentiation.
Lin R; Ding Z; Ma H; Shi H; Gao Y; Qian W; Shi W; Sun Z; Hou X; Li X
Stem Cells; 2015 Dec; 33(12):3545-57. PubMed ID: 26302722
[TBL] [Abstract][Full Text] [Related]
8. De novo formation of large arteriovenous shunting and a vascular nidus mimicking an arteriovenous malformation within an anaplastic oligodendroglioma: treatment with embolization and resection.
McKinney JS; Steineke T; Nochlin D; Brisman JL
J Neurosurg; 2008 Dec; 109(6):1098-102. PubMed ID: 19035725
[TBL] [Abstract][Full Text] [Related]
9. De Novo Arteriovenous Malformation in a Pediatric Patient: Case Report and Review of the Literature.
Santos R; Aguilar-Salinas P; Entwistle JJ; Aldana PR; Beier AD; Hanel RA
World Neurosurg; 2018 Mar; 111():341-345. PubMed ID: 29294397
[TBL] [Abstract][Full Text] [Related]
10. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
Reinders ME; Dreyer GJ; Bank JR; Roelofs H; Heidt S; Roelen DL; Zandvliet ML; Huurman VA; Fibbe WE; van Kooten C; Claas FH; Rabelink TJ; de Fijter JW
J Transl Med; 2015 Nov; 13():344. PubMed ID: 26537851
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure.
Kuzmina LA; Petinati NA; Sats NV; Drize NJ; Risinskaya NV; Sudarikov AB; Vasilieva VA; Drokov MY; Michalzova ED; Parovichnikova EN; Savchenko VG
Int J Hematol; 2016 Sep; 104(3):403-7. PubMed ID: 27169613
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
[TBL] [Abstract][Full Text] [Related]
13. De novo arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia.
Shimoda Y; Osanai T; Nakayama N; Ushikoshi S; Hokari M; Shichinohe H; Abumiya T; Kazumata K; Houkin K
J Neurosurg Pediatr; 2016 Mar; 17(3):330-5. PubMed ID: 26613274
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy in treatment of erectile dysfunction: autologous or allogeneic cell sources?
Mangir N; Akbal C; Tarcan T; Simsek F; Turkeri L
Int J Urol; 2014 Dec; 21(12):1280-5. PubMed ID: 25074479
[TBL] [Abstract][Full Text] [Related]
15. De novo development of a cerebral arteriovenous malformation following radiation therapy: Case report and an update to classical arteriovenous malformation nomenclature.
Koch MJ; Agarwalla PK; Stapleton CJ; Ogilvy CS; Loeffler JS
J Clin Neurosci; 2016 Jun; 28():162-7. PubMed ID: 26860850
[TBL] [Abstract][Full Text] [Related]
16. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Kallekleiv M; Larun L; Bruserud Ø; Hatfield KJ
Cytotherapy; 2016 Feb; 18(2):172-85. PubMed ID: 26794711
[TBL] [Abstract][Full Text] [Related]
17. Effects of Combined Transplantation of Multipotent Mesenchymal Stromal and Hemopoietic Stem Cells on Regeneration of the Hemopoietic Tissue.
Maklakova IY; Grebnev DY
Bull Exp Biol Med; 2017 May; 163(1):61-64. PubMed ID: 28580523
[TBL] [Abstract][Full Text] [Related]
18. Acute dysautonomia and arteriovenous malformation of the brain stem.
Monseu G; Lacroix E; Bauherz G; Baleriaux D
Acta Neurol Belg; 1983; 83(5):233-45. PubMed ID: 6670459
[TBL] [Abstract][Full Text] [Related]
19. Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-β.
Yoo SW; Chang DY; Lee HS; Kim GH; Park JS; Ryu BY; Joe EH; Lee YD; Kim SS; Suh-Kim H
Neurobiol Dis; 2013 Oct; 58():249-57. PubMed ID: 23759293
[TBL] [Abstract][Full Text] [Related]
20. Treating congenital megacolon by transplanting GDNF and GFRα-1 double genetically modified rat bone marrow mesenchymal stem cells.
Zhou CB; Peng CH; Pang WB; Zhang D; Chen YJ
Genet Mol Res; 2015 Aug; 14(3):9441-51. PubMed ID: 26345878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
